Ulge, Umut Y.

509 A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer

Regular and Young Investigator Award Abstracts | November 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: A540-A540

10.1136/jitc-2021-sitc2021.509